Brief: ClouDr Group Enters Strategic Cooperation Agreement With Medice
04/09/2024 11:18
Sept 4 (Reuters) - ClouDr Group Ltd 9955.HK :
* STRATEGIC COOPERATION AGREEMENT WITH MEDICE
* DEAL TO GRANT 5-YEAR EXCLUSIVE RIGHTS TO IMPORT, OTHERS,
AND
PROMOTE REMIFEMIN AND ESBERITOX IN HOSPITALS AND PHARMACIES IN
CHINA
Further company coverage: 9955.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ClouDr
See all newsBrief: Cloudr Group Posts FY Revenue RMB 1,623.2 Million
Brief: Cloudr Says Co Expects FY Net Loss Between Rmb880 Million And Rmb980 Million
Brief: ClouDr Group Proposes Issue Of Convertible Bonds Under General Mandate
China's ClouDr rises to 4-month high on medical AI integration with DeepSeek-R1 model
Brief: Cloudr Announces Improvement Of Cloudr Brain Through Integration Of DeepSeek